Leonard and his team have developed a technology for engineering human cell-based ‘devices’ that monitor and modify human physiology. This technology is a protein biosensor that sits on the surface of a cell, can be programmed to sense specific external factors, and upon detecting these factors sends a signal into the engineered cell’s nucleus to activate a gene expression program.
Building ‘Smart’ Cell-Based Therapies
A Northwestern synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.
Engineering cell-based, biological devices that monitor and modify human physiology is a promising frontier in clinical synthetic biology. However, no existing technology enabled bioengineers to build such devices that sense a patient’s physiological state and respond in a customized fashion.
“The project addressed a key gap in the synthetic biology toolbox,” says Joshua Leonard, assistant professor of chemical and biological engineering in Northwestern’s McCormick School of Engineering and Applied Science. “There was no way to engineer cells in a manner that allowed them to sense key pieces of information about their environment, which could indicate whether the engineered cell is in healthy tissue or sitting next to a tumor.”
Funded by the National Academies Keck Futures Initiative and the Defense Advanced Research Projects Agency, the research is available to read online in the journal ACS Synthetic Biology.
Leonard’s team worked for nearly four years to close this gap. The end result is a protein biosensor that sits on the surface of a cell and can be programmed to sense specific external factors. For example, the engineered cell could detect big, soluble protein molecules that indicate that it’s next to a tumor. When the biosensor detects such a factor, it sends a signal into the engineered cell’s nucleus to activate a gene expression program, such as the production of tumor-killing proteins or chemicals. Since this toxic program would be activated only near tumor cells, such an approach could minimize side effects as well as improve therapeutic benefits.
Called a Modular Extracellular Sensor Architecture (MESA), the biosensor platform is completely self-contained so that several different biosensors can be present in a single cell without interfering with one another, allowing bioengineers to build increasingly sophisticated functional programs. The platform is also highly modular, enabling the biosensors to be customized to recognize factors of relevance to various patients’ needs.
“By linking the output of these biosensors to genetic programs, one can build in a certain logical command, such as ‘turn the output gene on when you sense this factor but not that factor,’” Leonard explains. “In that way, you could program a cell-based therapy to specify which cells it should kill.”
Leonard says doctors could potentially collect immune cells from a patient’s body, engineer the cells using MESA, and put them back into the patient. From there, the cells would do the work of detecting cancer or the disease they are designed to identify.
The Latest on: Smart Cell-Based Therapies
via Google News
The Latest on: Smart Cell-Based Therapies
- Nanotech imaging device shows potential to make disease diagnosis with smartphoneson May 12, 2022 at 2:59 pm
A nanotech imaging device, tiny enough to fit on a smartphone camera lens, has the potential to make the diagnosis of certain diseases accessible and affordable for people in rural and remote regions, ...
- Technologyon May 10, 2022 at 4:31 am
Google announced Monday it will allow ads for stem cell treatments approved ... frustration due to the lack of a smart AC controller. The unit doesn’t have even the most basic smart features like time ...
- Scientists reveal retinal cell mapping could promote accurate therapies for blindnesson May 7, 2022 at 2:30 am
Bethesda (Maryland) [US], May 7 (ANI): Researchers have identified discrete differences between the cells that make up retinal tissue and the findings can help in developing targeted therapies to ...
- MIT scientists claim they can reverse hearing loss with a 2-hour treatmenton May 3, 2022 at 5:37 am
Don't Miss: Monday’s deals: $5 Amazon Smart Plug, Shark vacuums ... Instead, the biotech company wants to use a new kind of regenerative therapy to repair the tiny hair cells that allow us to hear. As ...
- Animal Stem Cell Therapy Market 2022 Trends, Share, Size, Growth, Opportunity and Forecast to 2025on April 28, 2022 at 1:27 pm
It could, thus, be inferred that with “smart cities” would come ... robust growth of the animal stem cell therapy market. There are little evidence-based preclinical animal studies acts ...
- CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and ...on April 22, 2022 at 5:39 am
CareDx will also share information about its OTTR® Patient Management Software that has recently been validated to SMART ... stem cell transplants or being treated with allogeneic cell therapies ...
- Toolkit Enables Safer and More Efficient Therapeutic Cellson April 19, 2022 at 4:12 am
Therapies based on engineered immune cells have recently emerged as ... to precisely control when and where the therapeutic T cell is active. “These smart cell therapies can unleash potent therapeutic ...
- A new toolkit to engineer safe and efficient therapeutic cellson April 15, 2022 at 10:10 am
Therapies based on engineered immune cells have recently ... when and where the therapeutic T cell is active. "These smart cell therapies can unleash potent therapeutic activity precisely at ...
- A new toolkit to engineer safe and efficient therapeutic cellson April 15, 2022 at 9:15 am
“These smart cell therapies can unleash potent ... However, the original synNotch receptor is difficult to deploy for cell-based therapy in humans. For one thing it is bulky, which makes it ...
- A comprehensive rule book for the design of safe and efficient therapeutic cellson April 14, 2022 at 5:01 pm
Therapies based on engineered immune cells have recently ... when and where the therapeutic T cell is active. These smart cell therapies can unleash potent therapeutic activity precisely at ...
via Bing News